title: Long-term outcome of chronic myeloid leukaemia patients with p210 and p190 co-expression at baseline.
authors.affiliation: Department of Cellular Biotechnologies and Haematology, Sapienza University, Rome, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Molica
authors.forename: Irene
authors.initials: I
authors.lastname: Zacheo
authors.forename: Daniela
authors.initials: D
authors.lastname: Diverio
authors.forename: Giuliana
authors.initials: G
authors.lastname: Alimena
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016208:Databases, Factual; D018572:Disease-Free Survival; D005260:Female; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000096:biosynthesis*; D010677:Philadelphia Chromosome; D012189:Retrospective Studies; D015996:Survival Rate
chemical_list: D015514:Oncogene Proteins, Fusion
keywords: chronic myeloid leukaemia; imatinib; interferon; p190; prognosis